Physician profile
Opal Patel
NPI 1114547056
$5,398.84
in general payments reported to CMS, 2019-2025
21 companies · $1,385 in 2025
The $1,385 reported for 2025 was more than what 76% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $867 · 2023: $1,420 · 2024: $1,728 · 2025: $1,385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,878 · Travel and Lodging: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,877.73 |
| Travel and Lodging | $654.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,043.86 | 2022-2025 | Prostep, Ortholoc 3di, Variax |
| Biotissue Holdings INC. | $978.41 | 2024-2025 | |
| Integra Lifesciences Corporation | $459.30 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mimedx Group, INC. | $396.63 | 2024-2025 | |
| Smith+Nephew, INC. | $256.83 | 2023-2025 | Pico, Renasys Touch, Pico 14 |
| Bioventus LLC | $191.93 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Innovation Technologies INC | $175.30 | 2025 | Irrisept |
| Organogenesis INC. | $151.92 | 2024-2025 | Puraply Am, Puraply Wound Matrix |
| Paragon 28, INC. | $143.35 | 2024 | Grappler |
| Amgen INC. | $121.58 | 2024 | Krystexxa |
| Abbvie INC. | $99.95 | 2024-2025 | |
| Treace Medical Concepts, INC. | $92.06 | 2025 | |
| Averitas Pharma INC. | $61.76 | 2024 | Qutenza |
| Stimlabs LLC | $41.15 | 2025 | Corplex P |
| Solventum Corporation | $37.38 | 2024-2025 | Activ.A.C., V.A.C. Veraflo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $36.81 | 2024 | |
| Paratek Pharmaceuticals, INC. | $34.28 | 2024-2025 | Nuzyra |
| Dynasplint Systems INC. | $23.78 | 2025 | Dynasplint |
| Abbott Laboratories | $21.46 | 2024 | Eterna |
| Access Pro Medical, LLC | $18.75 | 2025 | Matriderm |
| Orthofix Medical, INC. | $12.35 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Opal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.